DGAP-PVR: Probiodrug AG: Release according to Article 26,

Probiodrug AG 

13.11.2015 17:00

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Probiodrug AG

Halle (Saale), Germany

Handelsregister: Amtsgericht Stendal, HRB 213719
(Commercial Register: Local Court of Stendal, HRB 213719)

ISIN: DE0007921835

Release pursuant to Article 26 Section 1 WpHG (Wertpapierhandelsgesetz -
German Securities Trading Act) with the objective of Europe-wide
distribution

Dissemination of notifications of voting rights pursuant to sec. 21 para. 1
WpHG (Wertpapierhandelsgesetz - German Securities Trading Act)

1.

Biotech Growth N.V., Willemstad, Curacao, the Netherlands Antilles (Dutch
Caribbean), informed our company pursuant to sec. 21 para. 1 WpHG (German
Securities Trading Act) on November 10, 2015, that its voting rights
proportion fell below the threshold of 15% of the voting rights in
Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN
DE0007921835, on November 9, 2015, and that its voting rights proportion in
Probiodrug AG amounted to 14.12% (corresponding to 1,050,784 voting rights)
on that date.

2. 

BB Biotech AG, Schaffhausen, Switzerland, informed our company pursuant to
sec. 21 para. 1 WpHG (German Securities Trading Act) on November 10, 2015,
that its voting rights proportion fell below the threshold of 15% of the
voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale),
Germany, ISIN DE0007921835, on November 9, 2015, and that its voting rights
proportion in Probiodrug AG amounted to 14.12% (corresponding to 1,050,784
voting rights) on that date.

14.12% (corresponding to 1,050,784 voting rights) are to be attributed to
BB Biotech AG pursuant to sec. 22 para. 1 sentence 1 no. 1 WpHG. The voting
rights that are to be attributed to BB Biotech AG are held via the
following controlled companies whose holdings of voting rights amount to 3%
or more in Probiodrug AG: Biotech Growth N.V.

3.

Kempen & Co N.V., Amsterdam, the Netherlands, informed our company pursuant
to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 12,
2015, that its voting rights proportion exceeded the thresholds of 3% and
5% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle
(Saale), Germany, ISIN DE0007921835, on November 9, 2015, and that its
voting rights proportion in Probiodrug AG amounted to 9.09% (corresponding
to 676,589 voting rights) on that date.

4.

F. van Lanschot Bankiers N.V., 's-Hertogenbosch, the Netherlands, informed
our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading
Act) on November 12, 2015, that its voting rights proportion exceeded the
thresholds of 3% and 5% of the voting rights in Probiodrug AG, Weinbergweg
22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 9, 2015,
and that its voting rights proportion in Probiodrug AG amounted to 9.09%
(corresponding to 676,589 voting rights) on that date.

9.09% (corresponding to 676,589 voting rights) are to be attributed to F.
van Lanschot Bankiers N.V. pursuant to sec. 22 para. 1 sentence 1 no. 1
WpHG. The voting rights that are to be attributed to F. van Lanschot
Bankiers N.V. are held via the following controlled companies whose
holdings of voting rights amount to 3% or more in Probiodrug AG: Kempen &
Co N.V.

5.

Van Lanschot N.V., 's-Hertogenbosch, the Netherlands, informed our company
pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on
November 12, 2015, that its voting rights proportion exceeded the
thresholds of 3% and 5% of the voting rights in Probiodrug AG, Weinbergweg
22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 9, 2015,
and that its voting rights proportion in Probiodrug AG amounted to 9.09%
(corresponding to 676,589 voting rights) on that date.

9.09% (corresponding to 676,589 voting rights) are to be attributed to Van
Lanschot N.V. pursuant to sec. 22 para. 1 sentence 1 no. 1 WpHG. The voting
rights that are to be attributed to Van Lanschot N.V. are held via the
following controlled companies whose holdings of voting rights amount to 3%
or more in Probiodrug AG: F. van Lanschot Bankiers N.V.; Kempen & Co N.V.

6.

Kempen & Co N.V., Amsterdam, the Netherlands, informed our company pursuant
to sec. 21 para. 1 WpHG (German Securities Trading Act) on November 12,
2015, that its voting rights proportion fell below the thresholds of 5% and
3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle
(Saale), Germany, ISIN DE0007921835, on November 10, 2015, and that its
voting rights proportion in Probiodrug AG amounted to 0.00% (corresponding
to 0 voting rights) on that date.

7.

F. van Lanschot Bankiers N.V., 's-Hertogenbosch, the Netherlands, informed
our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading
Act) on November 12, 2015, that its voting rights proportion fell below the
thresholds of 5% and 3% of the voting rights in Probiodrug AG, Weinbergweg
22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 10, 2015,
and that its voting rights proportion in Probiodrug AG amounted to 0.00%
(corresponding to 0 voting rights) on that date.

8.

Van Lanschot N.V., 's-Hertogenbosch, the Netherlands, informed our company
pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on
November 12, 2015, that its voting rights proportion fell below the
thresholds of 5% and 3% of the voting rights in Probiodrug AG, Weinbergweg
22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on November 10, 2015,
and that its voting rights proportion in Probiodrug AG amounted to 0.00%
(corresponding to 0 voting rights) on that date.

Halle (Saale), in November 2015

The Management 



13.11.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Probiodrug AG
              Weinbergweg 22
              06120 Halle/Saale
              Germany
Internet:     www.probiodrug.de
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------
DGAP-PVR: Probiodrug AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
